EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Optima Health plc (OPT) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Optima Health plc £0.64, price £2.46, upside -74.0%, quality 56 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · GB · ISIN GB00BRSCY602

OH Broad data Sep 23, 2026

Optima Health plc

OPT · LSE

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value £0.6400 · Strongly overvalued (−74%)
!Quality 56/100
!Expensive Growth (revenue 3y +67.4 %/yr)
!Thin margins · 3.1% net margin (TTM)
!negative free cash flow
✓Ranks above peers (9/12)
!Narrow moat 32/100
!Weak on past: 8 out of 100
Watch Optima Health plc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

£2.55 £1.40 Fair Value £0.6400 Sep 2024 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

24‑month range £1.40 – £2.55 · fair‑value band £0.4000 – £0.6400 · the £2.46 price screens above the £0.6400 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Optima Health in your weekly email

Every Wednesday you see whether Optima Health is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Optima Health plc provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.

Show more

Optima Health plc provides occupational health and wellbeing services for the public and private sectors in the United Kingdom. The company offers strategy and advisory services; risk and compliance services comprising health surveillance, pre-placement, fitness for work, immunizations, and pensions; performance and attendance services, including attendance and productivity management; engagement and wellbeing services through digital platforms, health assessments, and onsite activities; mental health services; and musculoskeletal health services. It serves the energy and utilities, construction, manufacturing, rail, transport, and financial sectors; and NHS, central, and local governments. The company was founded in 1947 and is headquartered in Sheffield, the United Kingdom.

Stock analysis

Optima Health plc (OPT) currently trades at £2.46, while our model-based Fair Value estimate is £0.6400, implying the stock looks roughly 284.3% overvalued today.

Show more

Valuation

Bull case: the Dividend Discount group reads highest at a median of £2.11 per share, and 0 of the 17 models we run sit above the £2.46 price.

Bear case: the Economic Profit group reads lowest at £0.3100, and 17 of the 17 models stay below the price. Evidence for this calculation is high.

Scenario range: £0.4000 (bear) to £0.6400 (bull), the price of £2.46 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 56/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Optima Health plc reported revenue of £105M in FY2025 versus £22.4M in FY2022, a compound +67.4%/yr. Reported net income was £1.7M in FY2025.

Key figures

Market cap 209M GBX · P/E ratio 20.5 · P/S ratio 0.32 · EPS (TTM) £0.1200 · Dividend yield 9.9% · Net margin 1.6% · Return on equity 2.1% · Return on assets (EBIT) 0.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 4% below its 52-week high and 38% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −74%, OPT screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (£0.2600 to £2.23). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear £0.4000 Fair Value £0.6400 Bull £0.6400
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then (£0.1200 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income £0.9600 £0.8800 £0.5500 73
EPV £0.2900 £0.3100 £0.3200 70
Owner Earnings £1.03 £1.90 £3.41 67
All 17 models by family
DCF Models
Owner Earnings £1.03 £1.90 £3.41 67
Earnings-Based
Graham-Dodd £0.1000 £0.7200 £1.01 60
Lynch FV £0.3100 £0.4400 £0.5700 58
PEG = 1.0 £0.3100 £0.4400 £0.5700 55
EPV £0.2900 £0.3100 £0.3200 70
Dividend Discount
Gordon GGM £1.33 £2.23 £2.89 66
DDM Multi-Stage £1.33 £2.11 £2.39 65
Multiples
P/E Multiple £0.2500 £0.3300 £0.4200 63
P/S Multiple £0.1900 £0.2600 £0.3200 58
P/B Multiple £0.1900 £0.2600 £0.3200 55
EV/EBIT £0.5200 £0.6400 £0.7700 63
EV/EBITDA £1.45 £1.89 £2.33 64
EV/Revenue £0.4100 £0.5200 £0.6400 52
Asset-Based
NCAV (Graham) £0.7700 £1.04 £1.55 51
Economic Profit
Residual Income £0.9600 £0.8800 £0.5500 73
ROIC Compounder £0.2900 £0.3100 £0.3200 67
Growth Earnings
Growth-Adj P/E £0.3900 £0.5500 £0.7200 65

Open the full fair value analysis →

Notify me when OPT reaches fair value

Put OPT on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 56/100

Of which business quality 55 · Market factors (momentum, volatility) 73

Profitability 23
Margins and returns on capital today
Quality Growth 43
Are margins and returns improving?
Cashflow 28
Earnings quality: real cash, not paper profit
Fin. Strength 85
Balance sheet, leverage, solvency risk
Investment 73
Disciplined investing over empire-building
Low Volatility 86
Calm price path (market factor)
Momentum 70
Price trend over the last 3–12 months (market factor)
52W Momentum 65
Distance to the 52-week high (market factor)
Net Issuance 100
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−5.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+67.4%
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+31.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+21.5%
Dividend (yield on the price)9.9%
Profit margin 2022 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−2% → 3%

OPT screens 284% overvalued. Compare with Veeva Systems Inc →

Compare Optima Health plc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks

Beats the industry median on 8/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 56 · Above median
Fair Value upside −74% · Bottom 25%
Profitability
Return on equity (TTM) 2% · Above median
Return on assets 2% · Above median
Net margin (TTM) 3% · Above median
Operating margin (TTM) 4% · Above median
Growth and dividend
Revenue growth 17% · Above median
Dividend yield (TTM) 9.9% · Top 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/E (TTM) 20.5× · Cheaper than median
P/B 1.65× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM) 2.43× · Pricier than median
EV/EBITDA 23.0× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 3
FUTURE (revenue growth)86 · sector 34
PAST (return on equity)8 · sector 5
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)100 · sector 48

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $270.75 $297.83 +10%
Pro Medicus Limited PME A$161.31 A$64.50 −60%
BrightSpring Health Services, Inc BTSG $56.55 $26.07 −54%
HealthEquity, Inc HQY $91.75 $100.93 +10%
Hinge Health, Inc HNGE $94.15 $51.66 −45%
10x Genomics, Inc TXG $80.70 $21.71 −73%
Waystar Holding WAY $25.63 $28.19 +10%
XtalPi Holdings 2228 HK$8.39 HK$1.50 −82%
Doximity, Inc DOCS $26.51 $31.41 +18%
Privia Health Group PRVA $19.46 $5.26 −73%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Optima Health plc · Fair Value
£0.6400 −284%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Optima Health plc Fair Value". https://www.fairvalue-calculator.com/stock/OPT

Frequently asked questions

Is Optima Health plc (OPT) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of £0.6400 versus a price of £2.46, about −74% upside (overvalued).
What is the fair value of OPT?
Our model-based fair value for Optima Health plc is £0.6400 (as of Sep 23, 2026), built from audited fundamentals. The current price: £2.46.
What is the quality score of OPT?
Optima Health plc has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Optima Health plc (OPT)?
Our model-based price target is the fair value of £0.6400 (as of Sep 23, 2026) from 17 valuation models. Cautious scenario £0.4000, optimistic scenario £0.6400. It is a calculation from audited fundamentals, not an analyst target.
What is the Optima Health plc stock forecast for 2026?
Our models put fair value at £0.6400, about −74% upside versus a price of £2.46 (overvalued). Cautious scenario £0.4000, optimistic scenario £0.6400. The calculation is refreshed regularly with new filings.
What is the revenue of Optima Health plc (OPT)?
Optima Health plc reported trailing-twelve-month revenue of about £114M (latest available figure, as of Sep 23, 2026).
Does Optima Health plc pay a dividend?
Optima Health plc currently shows a dividend yield of about 9.91% relative to its recent price (as of Sep 23, 2026).
What is the intrinsic value of Optima Health plc (OPT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Optima Health plc it is £0.6400 per share (as of Sep 23, 2026), against a price of £2.46. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Optima Health plc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, OPT trades above its calculated fair value: price £2.46, fair value £0.6400, a gap of about −74% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of OPT?
No. The price is what the market pays today (£2.46); the fair value is what the company's own numbers justify (£0.6400). For Optima Health plc the two are £1.82 per share apart. That gap is exactly why we show both numbers side by side.
How much is Optima Health plc worth?
The market values Optima Health plc at about 209M GBX (market capitalisation, as of Sep 23, 2026). Per share that is £2.46; our models calculate a fair value of £0.6400 per share.
What do the bullish and bearish scenarios say about OPT?
Our models span a range for Optima Health plc: cautious scenario £0.4000, base £0.6400, optimistic £0.6400 per share (as of Sep 23, 2026, price £2.46). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of OPT?
Optima Health plc trades at a price-to-earnings ratio of 20.5 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of £0.6400 is built from several models across several years. Other multiples: P/B 1.7, P/S 2.4, EV/EBITDA 23.0.
How solid is the balance sheet of Optima Health plc (OPT)?
Balance-sheet figures for Optima Health plc (as of Sep 23, 2026): return on equity 2.1%. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is OPT from its 52-week high?
Optima Health plc trades at £2.46, about 4% below its 52-week high of £2.55 and 38% above the low of £1.78 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of £0.6400 is for.
Which stocks are comparable to Optima Health plc?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Optima Health plc stock attractive at the current price?
The data as of Sep 23, 2026: price £2.46, calculated fair value £0.6400 (−74%), Quality Score 56/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of OPT calculated?
We run Optima Health plc through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of £0.6400, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Optima Health plc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Optima Health plc (OPT)?
The closing price on Sep 24, 2026 was £2.46. Our model-based fair value is £0.6400, about −74% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Optima Health plc right now?
The price sits above even our optimistic bull case (£0.6400). The favourable scenario is already priced in. Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Optima Health plc

How large is the market capitalisation of Optima Health plc (OPT)?
The market capitalisation of Optima Health plc is 209M GBX. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Optima Health plc (OPT)?
The price-to-sales ratio of Optima Health plc is 0.32 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Optima Health plc (OPT)?
Earnings per share at Optima Health plc are £0.1200 (price ÷ EPS = P/E 20.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Optima Health plc (OPT)?
The dividend yield of Optima Health plc is 9.9%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Optima Health plc (OPT)?
The net margin of Optima Health plc is 1.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Optima Health plc (OPT)?
The return on equity (ROE) of Optima Health plc is 2.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Optima Health plc (OPT)?
On an EBIT basis the return on assets of Optima Health plc is 0.3% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Optima Health plc (OPT)?
The operating margin of Optima Health plc is 4.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Optima Health plc (OPT)?
Revenue at Optima Health plc is growing +17.2% versus a year earlier (3y avg +67.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Optima Health plc (OPT) generate?
The free cash flow of Optima Health plc is −1.1M GBX (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Optima Health plc (OPT) carry?
The net debt of Optima Health plc is 6.9M GBX (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Optima Health plc in the live analysis

One click puts Optima Health plc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.